Funded Tech Companies

Vico Therapeutics

Headquartered in Leiden, Vico Therapeutics is venture-backed, with investment from Polaris Partners, Ackermans & Van Haaren and Seroba Life Sciences.

Company Overview

Contact Information

Company Background Information

Overview

Vico Therapeutics is a clinical-stage genetic medicines company developing antisense oligonucleotide (ASO) RNA modulating therapies for patients with severe neurological diseases. Our lead product candidate, VO659, is currently in Phase 1/2a clinical development for the treatment of spinocerebellar ataxia types 3 and 1 and Huntington's disease and is the only ASO in the clinic that targets the underlying CAG repeat expansions that cause all nine known polyglutamine diseases.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/24/2024

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Micah Mackison

        

Chief Medical Officer

Scott Schobel

        

Chief Scientific Officer

Nicole Datson

        

Company Investors

• Polaris Partners
• Ackermans & Van Haaren
• Seroba Life Sciences (Catello Somma)
• Droia Ventures
• Eurazeo
• Kurma Partners (Daniel Parera)
• Pureos Bioventures
• EQT Life Sciences

Browse more funded tech companies:

Vico Software | Victor

Share this article

About Our VC & M&A Database

Our data comes from VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary